Allen Capital Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $597K | Buy |
3,217
+348
| +12% | +$64.6K | 0.06% | 163 |
|
|
2025
Q1 | $601K | Buy |
2,869
+91
| +3% | +$19.1K | 0.07% | 142 |
|
|
2024
Q4 | $494K | Buy |
2,778
+337
| +14% | +$59.9K | 0.06% | 151 |
|
|
2024
Q3 | $482K | Buy |
2,441
+279
| +13% | +$55.1K | 0.06% | 145 |
|
|
2024
Q2 | $371K | Buy |
2,162
+197
| +10% | +$33.8K | 0.05% | 147 |
|
|
2024
Q1 | $358K | Buy |
1,965
+361
| +23% | +$65.7K | 0.05% | 145 |
|
|
2023
Q4 | $249K | Buy |
+1,604
| New | +$249K | 0.04% | 155 |
|